Switching from Neutral Protamine Hagedorn (NPH) Insulin to Insulin Glargine 300 U/mL in Older and Younger Patients with Type 2 Diabetes: A Post Hoc Analysis of a Multicenter, Prospective, Observational Study

被引：0
|
作者：
B. Wolnik
A. Hryniewiecki
D. Pisarczyk-Wiza
T. Szczepanik
T. Klupa
机构：
[1] Medical University of Gdańsk,Department of Hypertension and Diabetology
[2] Sanofi-Aventis Poland,Diabetes Division
[3] Medical University of Poznan,Department of Internal Diseases and Diabetology
[4] Starkiewicz Hospital,Zaglebie Oncology Center
[5] Jagiellonian University Medical College,Department of Metabolic Diseases
来源：
Diabetes Therapy | 2022年 / 13卷
关键词：
Type 2 diabetes; Elderly; Hypoglycemia; Insulin; NPH; Glargine 300;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：301 / 310
页数：9
相关论文
共 50 条
  • [21] A comparison of bedtime insulin glargine with bedtime neutral protamine hagedorn insulin in patients with type 2 diabetes: Subgroup analysis of patients taking once-daily insulin in a multicenter, randomized, parallel group study
    Fonseca, V
    Bell, DS
    Berger, S
    Thomson, S
    Mecca, TE
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2004, 328 (05): : 274 - 280
  • [22] An analysis of the cost-effectiveness of switching from biphasic human insulin 30, insulin glargine, or neutral protamine Hagedorn to biphasic insulin aspart 30 in people with type 2 diabetes
    Gupta, Vishal
    Baabbad, Ranya
    Hammerby, Eva
    Nikolajsen, Annie
    Shafie, Asrul Akmal
    JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (04) : 263 - 272
  • [23] Glycemic Variability and Time in Range During Self-titration of Once Daily Insulin Glargine 300 U/ml Versus Neutral Protamine Hagedorn Insulin in Insulin-naïve Chinese Type 2 Diabetes Patients
    James Ling
    Emily W. M. Poon
    Aimin Yang
    Theresa Yeung
    Kitman Loo
    Risa Ozaki
    Ronald C. W. Ma
    Andrea O. Y. Luk
    Alice P. S. Kong
    Juliana C. N. Chan
    Elaine Chow
    Diabetes Therapy, 2021, 12 : 1399 - 1413
  • [24] COST-UTILITY ANALYSIS OF INSULIN GLARGINE 300 U/ML VERSUS INSULIN GLARGINE 100 U/ML AND INSULIN DEGLUDEC 100 U/ML IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CROATIA
    Bogdanovic, M.
    Fournier, M.
    Vitezic, D.
    VALUE IN HEALTH, 2018, 21 : S131 - S132
  • [25] Efficacy and Safety of Switching from Insulin Glargine 100 U/mL to the Same Dose of Glargine 300 U/mL in Japanese Type 1 and 2 Diabetes Patients: A Retrospective Analysis
    Nakanishi, Shuhei
    Iwamoto, Masahiro
    Kamei, Shinji
    Hirukawa, Hidenori
    Shimoda, Masashi
    Tatsumi, Fuminori
    Kohara, Kenji
    Obata, Atsushi
    Kimura, Tomohiko
    Kinoshita, Tomoe
    Irie, Shintaro
    Sanada, Junpei
    Fushimi, Yoshiro
    Nishioka, Momoyo
    Mizoguchi, Akiko
    Kameyama, Miyuki
    Mune, Tomoatsu
    Kaku, Kohei
    Kaneto, Hideaki
    INTERNAL MEDICINE, 2018, 57 (10) : 1381 - 1389
  • [26] COST-UTILITY ANALYSIS OF INSULIN GLARGINE 300 U/ML VERSUS INSULIN GLARGINE 100 U/ML AND INSULIN DEGLUDEC 100 U/ML IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN BULGARIA
    Bogdanovic, M.
    Mihajlovic, J.
    Fournier, M.
    VALUE IN HEALTH, 2018, 21 : S133 - S133
  • [27] COST-EFFECTIVENESS ANALYSIS OF INSULIN DETEMIR VERSUS INSULIN NEUTRAL PROTAMINE HAGEDORN (NPH) IN PATIENTS WITH TYPE 1 DIABETES MELLITUS IN SPAIN
    Ramirez de Arellano, A.
    Lizan, L.
    Prades, M.
    Morales, C.
    De Luis, D.
    VALUE IN HEALTH, 2014, 17 (07) : A343 - A343
  • [28] CONFIRM: a comparative effectiveness study of insulin degludec and insulin glargine 300 units/ ml (glargine U300) in insulin-naive patients with type 2 diabetes
    Tibaldi, J.
    Haldrup, S.
    Sandberg, V.
    Wolden, M. L.
    Rodbard, H. W.
    DIABETOLOGIA, 2018, 61 : S44 - S44
  • [29] A comparative effectiveness study of degludec and insulin glargine 300 U/mL in insulin-naive patients with type 2 diabetes
    Tibaldi, Joseph
    Hadley-Brown, Martin
    Liebl, Andreas
    Haldrup, Steffen
    Sandberg, Viktor
    Wolden, Michael L.
    Rodbard, Helena W.
    DIABETES OBESITY & METABOLISM, 2019, 21 (04): : 1001 - 1009
  • [30] Improved Diabetes Medication Convenience in Persons with Type 2 Diabetes after Switching to Insulin Glargine 300 U/mL (U-300)-The Observational OPTIN-D Study
    Wieringa, Thomas H.
    De Wit, Maartje
    Twisk, Jos
    Snoek, Frank J.
    DIABETES, 2018, 67
12345